Implanon contraceptive implant: information for women and healthcare professionals

• From: Medicines and Healthcare products Regulatory Agency
• Published: 11 December 2014

• Therapeutic area: Obstetrics, gynaecology and fertility

Article date: January 2011

In light of recent media coverage regarding the contraceptive implant Implanon, we have highlighted our previous advice to support safer use of this product. This follows reports of problems with the insertion and removal of Implanon. Click here to view the information; further information about Implanon and the transition to a new version (called Nexplanon) is available from the October 2010 issue of Drug Safety Update.

Further information:

BNF section 7.3.2.2 Parenteral progestogen-only contraceptives

 

Article citation: Drug Safety Update Jan 2011, vol 4 issue 6: S3.

Published 11 December 2014